Your browser doesn't support javascript.
loading
Prognostic Significance of Primary Tumor Location in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Retrospective, Multi-Center Cohort Study in Taiwan.
Yu, Lian-Ching; Chang, Chao-Hsiang; Huang, Chi-Ping; Huang, Chao-Yuan; Hong, Jian-Hua; Tai, Ta-Yao; Weng, Han-Yu; Lo, Chi-Wen; Tsai, Chung-You; Lee, Yu-Khun; Tsai, Yao-Chou; Hsueh, Thomas Y; Chen, Yung-Tai; Chen, I-Hsuan; Chiang, Bing-Juin; Tseng, Jen-Shu; Wu, Chia-Chang; Lin, Wei-Yu; Chien, Tsu-Ming; Sheu, Zai-Lin; Li, Ching-Chia; Ke, Hung-Lung; Li, Wei-Ming; Lee, Hsiang-Ying; Wu, Wen-Jeng; Yeh, Hsin-Chih.
Afiliación
  • Yu LC; General Division, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
  • Chang CH; Department of Urology, China Medical University and Hospital, Taichung 40402, Taiwan.
  • Huang CP; Department of Urology, China Medical University and Hospital, Taichung 40402, Taiwan.
  • Huang CY; Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei 10002, Taiwan.
  • Hong JH; Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei 10002, Taiwan.
  • Tai TY; Institute of Biomedical Engineering, National Taiwan University, Taipei 10167, Taiwan.
  • Weng HY; Department of Urology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70403, Taiwan.
  • Lo CW; Department of Urology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70403, Taiwan.
  • Tsai CY; Institute of Biomedical Engineering, National Taiwan University, Taipei 10167, Taiwan.
  • Lee YK; School of Medicine, Buddhist Tzu Chi University, Hualien 97004, Taiwan.
  • Tsai YC; Division of Urology, Department of Surgery, Taipei Tzu Chi Hospital, The Buddhist Medical Foundation, New Taipei City 23142, Taiwan.
  • Hsueh TY; Division of Urology, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan.
  • Chen YT; Department of Healthcare Information & Management, Ming Chuan University, Taoyuan 33348, Taiwan.
  • Chen IH; Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien 97002, Taiwan.
  • Chiang BJ; Division of Urology, Department of Surgery, Taipei Tzu Chi Hospital, The Buddhist Medical Foundation, New Taipei City 23142, Taiwan.
  • Tseng JS; Department of Urology, Taipei Medical University Hospital, Taipei 11031, Taiwan.
  • Wu CC; Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Lin WY; Department of Urology, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan.
  • Chien TM; Division of Urology, Department of Surgery, Taipei City Hospital Renai Branch, Taipei 10629, Taiwan.
  • Sheu ZL; Department of Urology, School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan.
  • Li CC; Department of Urology, Taiwan Adventist Hospital, Taipei 10556, Taiwan.
  • Ke HL; Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 81362, Taiwan.
  • Li WM; College of Medicine, Fu-Jen Catholic University, New Taipei City 24205, Taiwan.
  • Lee HY; Department of Urology, Cardinal Tien Hospital, New Taipei City 23148, Taiwan.
  • Wu WJ; Department of Life Science, College of Science, National Taiwan Normal University, Taipei 11677, Taiwan.
  • Yeh HC; Department of Urology, Mackay Memorial Hospital, Taipei 10449, Taiwan.
J Clin Med ; 9(12)2020 Nov 27.
Article en En | MEDLINE | ID: mdl-33261187
ABSTRACT
We sought to examine the effect of tumor location on the prognosis of patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy (RNU). This retrospective study came from the Taiwan UTUC Collaboration Group, which consisted of 2658 patients at 15 institutions in Taiwan from 1988 to 2019. Patients with kidney-sparing management, both renal pelvic and ureteral tumors, as well as patients lacking complete data were excluded; the remaining 1436 patients were divided into two groups renal pelvic tumor (RPT) and ureteral tumor (UT), with 842 and 594 patients, respectively. RPT was associated with more aggressive pathological features, including higher pathological T stage (p < 0.001) and the presence of lymphovascular invasion (p = 0.002), whereas patients with UT often had synchronous bladder tumor (p < 0.001), and were more likely to bear multiple lesions (p = 0.001). Our multivariate analysis revealed that UT was a worse prognostic factor compared with RPT (overall survival HR 1.408, 95% CI 1.121-1.767, p = 0.003; cancer-specific survival HR 1.562, 95% CI 1.169-2.085, p = 0.003; disease-free survival HR 1.363, 95% CI 1.095-1.697, p = 0.006; bladder-recurrence-free survival HR 1.411, 95% CI 1.141-1.747, p = 0.002, respectively). Based on our findings, UT appeared to be more malignant and had a worse prognosis than RPT.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Año: 2020 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Año: 2020 Tipo del documento: Article País de afiliación: Taiwán